256 related articles for article (PubMed ID: 34698069)
1. From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry.
Kanduc D
Antibodies (Basel); 2021 Sep; 10(4):. PubMed ID: 34698069
[TBL] [Abstract][Full Text] [Related]
2. Exposure to SARS-CoV-2 and Infantile Diseases.
Kanduc D
Glob Med Genet; 2023 Jun; 10(2):72-78. PubMed ID: 37144240
[No Abstract] [Full Text] [Related]
3. Thromboses and Hemostasis Disorders Associated with COVID-19: The Possible Causal Role of Cross-Reactivity and Immunological Imprinting.
Kanduc D
Glob Med Genet; 2021 Dec; 8(4):162-170. PubMed ID: 34877574
[TBL] [Abstract][Full Text] [Related]
4. From Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Response to Cancer Onset via Molecular Mimicry and Cross-Reactivity.
Kanduc D
Glob Med Genet; 2021 Dec; 8(4):176-182. PubMed ID: 34877576
[No Abstract] [Full Text] [Related]
5. Molecular mimicry between SARS-CoV-2 and the female reproductive system.
Dotan A; Kanduc D; Muller S; Makatsariya A; Shoenfeld Y
Am J Reprod Immunol; 2021 Dec; 86(6):e13494. PubMed ID: 34407240
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mimicry between SARS-CoV-2 and Human Endocrinocytes: A Prerequisite of Post-COVID-19 Endocrine Autoimmunity?
Churilov LP; Normatov MG; Utekhin VJ
Pathophysiology; 2022 Aug; 29(3):486-494. PubMed ID: 36136066
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2-Induced Immunosuppression: A Molecular Mimicry Syndrome.
Kanduc D
Glob Med Genet; 2022 Sep; 9(3):191-199. PubMed ID: 35846107
[No Abstract] [Full Text] [Related]
8. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
9. From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry.
Kanduc D
Antibodies (Basel); 2020 Jul; 9(3):. PubMed ID: 32708525
[TBL] [Abstract][Full Text] [Related]
10. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
Cheng MH; Zhang S; Porritt RA; Noval Rivas M; Paschold L; Willscher E; Binder M; Arditi M; Bahar I
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25254-25262. PubMed ID: 32989130
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections.
Liu T; Feng M; Wen Z; He Y; Lin W; Zhang M
J Inflamm Res; 2021; 14():5475-5487. PubMed ID: 34720596
[TBL] [Abstract][Full Text] [Related]
12. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.
Stefano GB; Kream RM
Med Sci Monit; 2020 Nov; 26():e929789. PubMed ID: 33239605
[TBL] [Abstract][Full Text] [Related]
13. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
Root-Bernstein R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
[TBL] [Abstract][Full Text] [Related]
14. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
[TBL] [Abstract][Full Text] [Related]
15. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
Reche PA
Front Immunol; 2020; 11():586984. PubMed ID: 33178220
[TBL] [Abstract][Full Text] [Related]
16. The role of HMGB1 in COVID-19-induced cytokine storm and its potential therapeutic targets: A review.
Wulandari S; Hartono ; Wibawa T
Immunology; 2023 Jun; 169(2):117-131. PubMed ID: 36571562
[TBL] [Abstract][Full Text] [Related]
17. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
[TBL] [Abstract][Full Text] [Related]
18. Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin.
Sokolov AV; Isakova-Sivak IN; Mezhenskaya DA; Kostevich VA; Gorbunov NP; Elizarova AY; Matyushenko VA; Berson YM; Grudinina NA; Kolmakov NN; Zabrodskaya YA; Komlev AS; Semak IV; Budevich AI; Rudenko LG; Vasilyev VB
Biometals; 2023 Jun; 36(3):437-462. PubMed ID: 36334191
[TBL] [Abstract][Full Text] [Related]
19. Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.
Abela IA; Schwarzmüller M; Ulyte A; Radtke T; Haile SR; Ammann P; Raineri A; Rueegg S; Epp S; Berger C; Böni J; Manrique A; Audigé A; Huber M; Schreiber PW; Scheier T; Fehr J; Weber J; Rusert P; Günthard HF; Kouyos RD; Puhan MA; Kriemler S; Trkola A; Pasin C
mBio; 2024 Feb; 15(2):e0272223. PubMed ID: 38270455
[TBL] [Abstract][Full Text] [Related]
20. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
